NASDAQ:OFIX

Orthofix International N.v Stock News

etoro logo Buy OFIX
*Your capital is at risk
$11.80
+0.0100 (+0.0848%)
At Close: Jul 31, 2026
Orthofix Medical Inc (NASDAQ:OFIX) shares hit a new 52-week low on Tuesday after Sidoti lowered their price target on the stock from $70.00 to $56.00. Sidoti currently has a buy rating on the stock. O

Stocks That Hit 52-Week Lows On Thursday

12:00am, Thursday, 27'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 25) Arcutis Biotherapeutics...
We are upbeat about the year-over-year revenue growth recorded by majority of Orthofix's (OFIX) key operating segments in Q4.
We are upbeat about the year-over-year revenue growth recorded by majority of Orthofix's (OFIX) key operating segments in Q4.

80 Biggest Movers From Yesterday

10:32am, Wednesday, 26'th Feb 2020
Gainers Nemaura Medical Inc. (NASDAQ: NMRD) shares jumped 77.4% to close at $5.80 on Tuesday. Cocrystal Pharma Inc (NASDAQ: COCP) shares surged 64.7% to close at $2.19 on...
RA Medical Systems (NYSE:RMED) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of the

55 Stocks Moving In Tuesday's Mid-Day Session

05:24pm, Tuesday, 25'th Feb 2020
Gainers Cocrystal Pharma Inc (NASDAQ: COCP) climbed 79% to $2.38 S Mallinckrodt plc (NYSE: MNK) climbed 33.6% to $5.57 after the company announced a global opioid settlement...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Clovis Oncology (CLVS), Orthofix (OFIX) and Antibe Therapeutics (ATBPF).
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Clovis Oncology (CLVS – Research
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 24) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) Brainst
Orthofix price target lowered to $42 from $48 at Cantor Fitzgerald Cantor Fitzgerald OFIX
In a report released today, Craig Bijou from Cantor Fitzgerald maintained a Hold rating on Orthofix (OFIX), with a price target of $42.00. The company's
In a report released today, Craig Bijou from Cantor Fitzgerald maintained a Hold rating on Orthofix ( OFIX – Research Report ), with a price target of $42.00 . The company’s shares closed last Mon
Orthofix Medical (NASDAQ:OFIX) was upgraded by stock analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, ValuEngine reports. OFIX h
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE